8
Oct
2024

Sreepathi Pharmaceuticals Ltd

Exhibitor at CPHI Milan 2024 stand 2C110, API
About Us

Sreepathi Pharmaceuticals Ltd. was founded in 1986 and has been bought in 2006 by Mr. Srinivas Isola, MD of the Whitestar Group. Ever since the takeover in 2006, we have been the market leaders in Ciprofloxacin HCL and Ciprofloxacin Base. Currently we are the 2nd largest manufacturer of these products. We have always been known for our quality, manufacturing practices and custom manufacturing (In-House Specification) according to the clients specification.

  • IN
  • 2017
    On CPHI since
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Contact info
  • Plot No.22 B, (H.No.8-2-293/82/A/22/B), 500 033, Hyderabad, India
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 2C110, API

Products Featured at CPHI Milan 2024

  • Ciprofloxacin Base

    Product Ciprofloxacin Base

    Ciprofloxacin Base is a Fluoroquinolone Antibiotic used to treat Bacterial infections. Used as an injectable.
  • Ciprofloxacin HCL

    Product Ciprofloxacin HCL

    Ciprofloxacin HCL is Fluoroquinolone Antibiotic used to treat bacterial infections.
  • Levo-Acid, Levofloxacin Carboxylic Acid

    Product Levo-Acid, Levofloxacin Carboxylic Acid

    Levo Acid is a drug advance intermediate of Levofloxacin Hemihydrate. It is a chiral molecule in the antibiotic segment used to treat Bacterial infections.